期刊文献+

siRNA干预CTGF和TIMP-1对大鼠肝星状细胞胶原分泌的影响 被引量:3

siRNA Interference of CTGF and TIMP-1 on Rat Hepatic Stellate Cell Collagen Secretion
下载PDF
导出
摘要 目的研究小干扰RNA(small interfering RNA,siRNA)沉默结缔组织生长因子(connective tissue growthfactor,CTGF)和组织金属蛋白酶抑制剂-1(tissue inhibitor of matrix metalloproteinases,TIMP-1)对肝星状细胞(hepaticstellate cell,HSC)CTGF和TIMP-1基因表达以及对Ⅰ、Ⅲ型胶原分泌的影响。方法根据已筛选出的对CTGF和TIMP-1基因最有效的RNA干扰靶位,将化学合成siRNA CTGF和siRNA TIMP-1以脂质体LipofectamineTM2000介导,瞬时转染HSC-T6细胞,分别设siRNA CTGF组、siRNA TIMP-1组、siRNA CTGF和siRNA TIMP-1联合组、脂质体组及非特异性(negative control,NC)siRNA组,抽提转染24、48h细胞mRNA和蛋白,并收集细胞上清液。应用RT-PCR鉴定CTGF和TIMP-1mRNA的表达;Western blot检测其蛋白表达;ELISA法检测Ⅰ、Ⅲ型胶原的分泌。结果各干预组转染24、48h后分别与脂质体组和NC siRNA组比较,HSC-T6细胞CTGF及TIMP-1mRNA和蛋白表达均明显下调(均P<0.05),且干预组HSC-T6培养上清液中Ⅰ、Ⅲ型胶原含量明显减少(均P<0.05)。siRNA联合组分别与siRNA CTGF组和siRNA TIMP-1组比较,于转染48hsiRNA联合组较siRNA TIMP-1组抑制率高,细胞上清液中Ⅰ、Ⅲ型胶原量比siRNA TIMP-1组少,且差异具有统计学意义(均P<0.05);而与siRNA CTGF组比较,其CTGF mR-NA和蛋白抑制率增高,细胞上清液中Ⅰ、Ⅲ型胶原量较siRNA联合组减少,但差异无统计学意义(均P>0.05)。结论针对HSC-T6CTGF mRNA基因全长943位点和TIMP-1mRNA 304位点化学合成的siRNA,对靶基因mRNA和蛋白表达有较好的抑制效果,CTGF和TIMP-1沉默可显著减少细胞上清液中Ⅰ、Ⅲ型胶原含量;CTGF和TIMP-1两种基因同时沉默,有增强抗肝纤维化效果的可能。 Objective To investigate the effect of small interfering RNA(siRNA) targeting CTGF and TIMP 1 on type Ⅰ and Ⅲ collagen secretion in rat hepatic stellate cells. Methods The most effective siRNA targeting CTGF and TIMP-1 was transfected into HSC T6 cells by Lipofectamine package. Rat HSCs activated were divided into five groups: siRNA CTGF group,siRNA TIMP-1 group,siRNA CTGF combined with siRNA TIMP-1 group, Lipofectamine group and the negative con trol(NC) siRNA group. Total RNA and protein of the cells after transfection for 24 and 48 h were extracted, and the superna- tants were collected. The expression of CTGF and TIMP 1 was detected by using RT-PCR and Western blot. The contents of type Ⅰ and Ⅲ collagen in the supernatants were determined by using ELISA. Results As compared with NC siRNA and Lipo- fectamine groups,CTGF and TIMP-1 mRNA and protein expression levels were significantly decreased in the other treated groups after transfection for 24 and 48 h. The contents of type Ⅰ and Ⅲ collagen in the supernatants were significantly re- duced. The comparison of every treated group had statistically significant difference(P〈0.05). There was significant difference in the suppression rate of TIMP-1 mRNA and protein expression and secretion of type Ⅰ and Ⅲ collagen in HSC-T6 cells be tween siRNA TIMP 1 group and siRNA CTGF combined with siRNA TIMP-1 group after transfection for 48 h(P〈0.05), but there was no significant difference in the suppression rate of CTGF mRNA and protein expression between siRNA TIMP-1 group and siRNA CTGF combined with siRNA TIMP-1 group after transfection for 24 and 48 h(P〈0.05). Conclusion siRNA chemically synthesized targeting CTGF gene and TIMP-1 gene at site of 943 and 304 excellently inhibits the expression of mRNA and protein in HSC-T6 cells, siRNA CTGF and siRNA TIMP-1 could significantly reduce secretion of type Ⅰ and Ⅲ collagen. The combination of siRNA CTGF and siRNA TIMP-1 may promote the effect of suppressing hepatic fibrosis.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2012年第1期22-26,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 湖北省血吸虫防治项目(No.XF06C28 X 2010-15) 百洋肝纤维化基础研究项目(No.2010-009)
关键词 小干扰RNA 结缔组织生长因子 组织金属蛋白酶抑制剂-1 肝星状细胞 Ⅰ、Ⅲ型胶原 small interfering RNA CTGF TIMP-1 hepatic stellate cell type Ⅰ and Ⅲ collagen
  • 相关文献

参考文献12

  • 1Rachfal A W,Brigstock D R.Connective tissue growth factor(CTGF/CCN2)in hepatic fibrosis[J].Hepatol Res,2003,26(1):1-9.
  • 2Fenske D B,Cullis P R.Liposomal nanomedicines[J].Expert Opin Drug Deliv,2008,5(1):25-44.
  • 3Li G M,Li D G,Xie Q,et al.RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production[J].Gene Med,2008,10(9):1039-1047.
  • 4Albanis E,Friedmen S L.Hepatic fibrosis.Pathogenesis and principles of therapy[J].Chin Liver Dis,2001,5(2):315-334.
  • 5Duncan M R,Frazier K S,Abramson S,et al.Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis:down-regulation by cAMP[J].FASEB J,1999,13(13):1774-1786.
  • 6Kasaragod A B,Lucia M S,Cabirac G,et al.Connective tissue growth factor expression in prediatric myofibroblastic tumors[J].Pediatr Dev Pathol,2001,4(1):37-45.
  • 7Lipardi C,Wei Q,Paterson B M.RNAi as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs[J].Cell,2001,107(3):297-307.
  • 8Blom I E,Goldschmeding R,Leask A.Gene regulation of connective tissue growth factor:new targets for antifibrotic therapy[J].Matrix Biol,2002,21(6):473-482.
  • 9Wang J F,Olson M E,Ma L,et al.Connective tissue growth f-actor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts[J].Wound Repair Regen,2004,12(2):205-216.
  • 10Gupta S,Clarkson M B,Duggan J,et al.Connective tissue gr-owth factor:potential role in glomerulosclerosis and tubulointerstitial fibrosis[J].Kidney Int,2000,58(4):1389-1399.

二级参考文献11

  • 1Szapiel S,Elson N,Fulmer J,et al.Bleomycin-induced interstitial pulmonary disease in the nude,athymic mouse[J].Am Rev Respir Dis,1979,120(4):893-899.
  • 2Gong L K,Li X H,Wang H,et al.Feitai attenuates bleomycin-induced pulmonary fibrosis in rats[J].Biol Pharm Bull,2004,27(5):634-640.
  • 3Oggionni T,Morbini P,Inshilleri S,et al.Time course of matrix metallo2 proteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis[J].Eur J Histochem,2006,50(4):317-325.
  • 4Lambert E,Dasse E,Haye B,et al.TIMPs asmultifacial proteins[J].Crit Rwv Oncol Hematol,2004,49(3):187-198.
  • 5Taro H.Multiple functions of tissue inhibitors of metalloproteinases(TIMPs):a new aspect involving osteoclastic bone resorption[J].J Bone Miner Metab,2002,20(1):1-13.
  • 6Corbel M,Belleguic C,Boichot E,et al.Involvement of gelatinases(MMP-2 and MMP-9)in the development of airway inflammation and pulmonary fibrosis[J].Cell Biol Toxicol,2006,18(1):51-61.
  • 7Swlman M,Ruiz V,Cabrera S,et al.TIMP-1,-2,-3,and-4 in idiopathic pulmonary fibrosis.A prevailing nondeg-radative lung microenvironment[J].Am J Physiol Lung Cell Mol Physiol,2008,279(3):562-574.
  • 8Corbel M,Caulet S,Germain N,et al.Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix meta11oproteinase inhibitor batimastat[J].Arch Pathol Lab Med,2001,193(4):538-545.
  • 9Debra L,Fleeno R,Iok-Hou P,et al.Involvement of AP-1 in interleukin-1α stimulated MMP-3 expression in human trabecular meshwork cells[J].Invest Ophth Vis Sci,2003,44(8):3494-3501.
  • 10Mojgan H,Anastasia Y,Kaili S,et al.IL-1 and TNF induction of Matrix metalloproteinase-3 by c-jun N-terminal kinase in trabecular meshwork[J].Invest Ophth Vis Sci,2006,47(4):1469-1476.

共引文献3

同被引文献35

  • 1Ye-JiangZhou,Yu-XiaXiong,Xiao-TingWu,DeShi,WeiFan,TongZhou,Yue-ChunLi,XiongHuang.Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer[J].World Journal of Gastroenterology,2004,10(21):3225-3229. 被引量:31
  • 2Yu J W,Wu J G,Jiang B J,et al. Study on lymph node metas- tasis correlated to lymphangiogenesis, lymphatic vessel inva- sion and lymph node micrometastasis in gastric cancer[J]. J Surg Res,2011,168(2) : 188-196.
  • 3Chen D,Wang Y,Zhang K,et al. Antisense oligonucleotide a- gainst clusterin regulates human hepatocellular carcinoma in- vasion through transcriptional regulation of matrix metallo- proteinase-2 and e-cadherin[J]. Int J Mol Sci, 2012,13 (8): 10594-10607.
  • 4Guo X T, Wang J F, Zhang L Y, et al. Quantitative assess- ment of the effects of MMP-2 polymorphisms on lung carcino- ma risk[J]. Asian Pac J Cancer Prev,2012,13(6):2853-2856.
  • 5Koshikawa N, Mizushima H, Minegishi T, et al. Proteolytic activation of heparin-binding EGF-like growth factor by mem- brane-type matrix metalloproteinase-1 in ovarian carcinoma eells[J]. Cancer Sei,2011,102(1) :111-116.
  • 6Soubani O, Ali A S, Logna F, et al. Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer[J]. Carcinogenesis, 2012,33 (8) : 1563-1571.
  • 7Reis S T,Antunes A A,Pontes J Jr,et al. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer[J]. Int Braz J Urol, 2012,38 (2) :167-174.
  • 8Mohammad M A, Zeeneldin A A, Abd Elmageed Z Y, et al. Clinical relevance of cyclooxygenase-2 and matrix metallopro- teinases(MMP-2 and MT1-MMP) in human breast cancer tis- sue[J]. Mol Cell Biochem, 2012,366 (1/2) : 269-275.
  • 9AI-Raawi D, Abu-EI-Zahab H, EI-Shinawi M, et al. Memb- rane type I -matrix metalloproteinase (MT1-MMP) corre- lates with the expression and activation of matrix metallopro- teinase-2(MMP-2) in inflammatory breast cancer [J]. Int J Clin Exp Med,2011,4(4) :265-275.
  • 10Shi F,Sottile J. MT1-MMP regulates the turnover and endo- cytosis of extracellular matrix fibronectin[J]. J Cell Sci,2011, 124(Pt 23) :4039-4050.

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部